Drug Shortage Report for MYLAN-LANSOPRAZOLE

Last updated on 2018-03-02 History
Report ID 29854
Drug Identification Number 02353849
Brand name MYLAN-LANSOPRAZOLE
Common or Proper name LANSOPRAZOLE
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) LANSOPRAZOLE
Strength(s) 30MG
Dosage form(s) CAPSULE (DELAYED RELEASE)
Route of administration ORAL
Packaging size 100BT
ATC code A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2018-03-16
Actual start date
Estimated end date
Actual end date 2018-03-02
Shortage status Avoided shortage
Updated date 2018-03-02
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v38 2018-03-02 French Compare
v37 2018-03-02 English Compare
v36 2018-02-28 French Compare
v35 2018-02-28 English Compare
v34 2018-02-23 French Compare
v33 2018-02-23 English Compare
v32 2018-02-23 English Compare
v31 2018-01-25 English Compare
v30 2018-01-24 French Compare
v29 2018-01-24 English Compare
v28 2018-01-24 English Compare
v27 2017-12-27 English Compare
v26 2017-12-22 French Compare
v25 2017-12-22 English Compare
v24 2017-12-20 French Compare
v23 2017-12-20 English Compare
v22 2017-12-18 French Compare
v21 2017-12-18 English Compare
v20 2017-12-14 French Compare
v19 2017-12-14 English Compare

Showing 1 to 20 of 38